Blog · OCT 19, 2023 · 3 min read
DGHS Compliance for Pharma Marketing: A Plain-English Primer
DGHS guidelines don't ban reps from meeting doctors, they ban documenting the meeting as anything other than what it actually was.
Directorate General of Health Services guidance on pharmaceutical marketing practice gets summarized badly in most sales team briefings, usually as "no gifts, no sponsorship, be careful." That's not wrong, but it skips the part that actually determines whether a company's marketing spend survives an audit: documentation.
What the rules actually restrict
The core restrictions are narrower than most reps assume. Continuing medical education sponsorship is permitted when it funds the education, not the doctor's travel companions. Product samples are permitted within quantity and record-keeping limits, not as a substitute for detailing. Hospitality tied to a conference is permitted at a venue and scale appropriate to the event, not as a proxy for a holiday. None of this bans the underlying activity, it bans doing the activity without a paper trail that matches the stated purpose.
Where companies actually get flagged
In practice, enforcement issues rarely start with a banned activity. They start with a mismatch between what was recorded and what happened: a CME sponsorship logged as "marketing," a sample distribution log with more units shipped than doctors visited, a hospitality expense with no corresponding educational agenda on file. Auditors reading a compliance file are pattern-matching for inconsistency, not chasing every individual transaction.
The plain-English version
If a company can produce, for any given spend, a stated business purpose, a record of who approved it, and a document trail showing the money went where the purpose said it would, most DGHS-adjacent scrutiny resolves itself quickly. The categories that create risk are the ones without a clean chain: verbal approvals, samples logged in bulk instead of by recipient, and hospitality invoices that don't reference an educational or scientific event. None of this requires new software or a compliance department the size of the sales team. It requires treating every field expense as something that will eventually be read by someone who wasn't in the room.